Item 2.02. Results of Operations and Financial Condition.

On October 8, 2020, PURE Bioscience, Inc. (the "Company") issued a press release announcing financial results for the fiscal year ended July 31, 2020 and related information. A copy of the press release is attached as Exhibit 99.1.

The information in this Item 2.02 is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section. The information in this Item 2.02 shall not be incorporated by reference into any registration statement or other document filed with the Securities and Exchange Commission.

Item 9.01. Financial Statements and Exhibits.





(d) Exhibits



  99.1         Press Release, dated October 8 2020.

* Exhibit 99.1 is being furnished and shall not be deemed "filed" for the purposes

of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the

liabilities of that Section, nor shall it be incorporated by reference into any

registration statement or other document filed with the Securities and Exchange

Commission.

© Edgar Online, source Glimpses